Co-Authors
This is a "connection" page, showing publications co-authored by Chiara Agrati and Peter Galle.
Connection Strength
0.055
-
Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis. 2020 Jul; 96:431-439.
Score: 0.055